Protein for Premies
- Conditions
- Extreme Prematurity
- Registration Number
- NCT01773902
- Lead Sponsor
- University Hospital Tuebingen
- Brief Summary
Although expressed breast milk is considered the optimal nutritional source for preterm infants, the macronutrient content is insufficient to enable optimal growth during neonatal intensive care. Optimal dose and optimal mode of administration (standardized or individualized) of enteral protein supplementation to very preterm infants have not been established.
This study aims to compare the effects on weight gain of different modes of enteral protein supplementation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
- very preterm infants <32 weeks gestation and <1500g birth weight
- > 100ml/kg/d of enteral feeding
- missing informed consent
- decision not to feed breast milk
- congenital malformations
- age > 7 days at study entry
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Weight gain From birth - to the end of study intervention (anticipated to be on average 1 week before discharge home at approx 37 weeks PMA)
- Secondary Outcome Measures
Name Time Method Head circumference growth From birth - to the end of study intervention (anticipated to be on average 1 week before discharge home at approx 37 weeks PMA)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University Children's Hospital Tuebingen
🇩🇪Tuebingen, Germany
University Children's Hospital Tuebingen🇩🇪Tuebingen, Germany